Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

483 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting.
Ray-Coquard I, Trama A, Seckl MJ, Fotopoulou C, Pautier P, Pignata S, Kristensen G, Mangili G, Falconer H, Massuger L, Sehouli J, Pujade-Lauraine E, Lorusso D, Amant F, Rokkones E, Vergote I, Ledermann JA; RARECARENet Working Group. Ray-Coquard I, et al. Among authors: massuger l. Eur J Surg Oncol. 2019 Jan;45(1):67-74. doi: 10.1016/j.ejso.2017.09.025. Epub 2017 Nov 3. Eur J Surg Oncol. 2019. PMID: 29108961 Review.
Immunohistochemical expression of CD10 antigen in uterine adenosarcoma.
Amant F, Steenkiste E, Schurmans K, Verbist L, Abeler VM, Tulunay G, de Jonge E, Massuger L, Moerman P, Vergote I. Amant F, et al. Among authors: massuger l. Int J Gynecol Cancer. 2004 Nov-Dec;14(6):1118-21. doi: 10.1111/j.1048-891X.2004.14610.x. Int J Gynecol Cancer. 2004. PMID: 15571618
Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative.
Cuppens T, Annibali D, Coosemans A, Trovik J, Ter Haar N, Colas E, Garcia-Jimenez A, Van de Vijver K, Kruitwagen RP, Brinkhuis M, Zikan M, Dundr P, Huvila J, Carpén O, Haybaeck J, Moinfar F, Salvesen HB, Stukan M, Mestdagh C, Zweemer RP, Massuger LF, Mallmann MR, Wardelmann E, Mints M, Verbist G, Thomas D, Gommé E, Hermans E, Moerman P, Bosse T, Amant F. Cuppens T, et al. Clin Cancer Res. 2017 Mar 1;23(5):1274-1285. doi: 10.1158/1078-0432.CCR-16-2149. Clin Cancer Res. 2017. PMID: 28232476
Evaluation of a Web-Based Intervention for Patients with Gestational Trophoblastic Disease: A Randomized Controlled Trial.
Frijstein M, Blok L, Ten Kate-Booij M, Eysbouts Y, Trommel NV, Sweep F, Massuger L, V Hamont D, Schreuder H, Smink M, Molkenboer J, Vencken P, Ottevanger N, Lok C; Trophy Study Group. Frijstein M, et al. Among authors: massuger l. Gynecol Obstet Invest. 2023;88(2):98-107. doi: 10.1159/000529239. Epub 2023 Jan 20. Gynecol Obstet Invest. 2023. PMID: 36682348 Clinical Trial.
Adjunctive use of p16 immunohistochemistry for optimizing management of CIN lesions in a high-risk human papillomavirus-positive population.
Ebisch RMF, Rijstenberg LL, Soltani GG, van der Horst J, Vedder JEM, Hermsen M, Bosgraaf RP, Massuger LFAG, Meijer CJLM, Heideman DAM, van Kemenade FJ, Melchers WJG, Bekkers RLM, Siebers AG, Bulten J. Ebisch RMF, et al. Among authors: massuger lfag. Acta Obstet Gynecol Scand. 2022 Nov;101(11):1328-1336. doi: 10.1111/aogs.14459. Epub 2022 Sep 30. Acta Obstet Gynecol Scand. 2022. PMID: 36177908 Free PMC article.
Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-Analysis.
Steenbeek MP, van Bommel MHD, Bulten J, Hulsmann JA, Bogaerts J, Garcia C, Cun HT, Lu KH, van Beekhuizen HJ, Minig L, Gaarenstroom KN, Nobbenhuis M, Krajc M, Rudaitis V, Norquist BM, Swisher EM, Mourits MJE, Massuger LFAG, Hoogerbrugge N, Hermens RPMG, IntHout J, de Hullu JA. Steenbeek MP, et al. Among authors: massuger lfag. J Clin Oncol. 2022 Jun 10;40(17):1879-1891. doi: 10.1200/JCO.21.02016. Epub 2022 Mar 18. J Clin Oncol. 2022. PMID: 35302882 Free PMC article.
Survival Is Related to Estrogen Signal Transduction Pathway Activity in Postmenopausal Women Diagnosed with High-Grade Serous Ovarian Carcinoma.
van Lieshout L, van der Ploeg P, Wesseling-Rozendaal Y, van de Stolpe A, Bosch S, Lentjes-Beer M, Ottenheijm M, Meriaan A, Vos C, de Hullu J, Massuger L, Bekkers R, Piek J. van Lieshout L, et al. Among authors: massuger l. Cancers (Basel). 2021 Oct 12;13(20):5101. doi: 10.3390/cancers13205101. Cancers (Basel). 2021. PMID: 34680250 Free PMC article.
Diagnosis and management of gestational trophoblastic disease: 2021 update.
Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, Lurain JR, Massuger L. Ngan HYS, et al. Among authors: massuger l. Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1(Suppl 1):86-93. doi: 10.1002/ijgo.13877. Int J Gynaecol Obstet. 2021. PMID: 34669197 Free PMC article.
483 results